Overview
What is American Association For The Study Of Liver Diseases?
The American Association for the Study of Liver Diseases (AASLD) is a distinguished nonprofit organization situated in Alexandria, Virginia. Its primary focus is to advance and disseminate knowledge in the field of hepatology, aiming to improve liver health and patient care. This is achieved through various publications such as "Hepatology," "Liver Transplantation," "Clinical Liver Disease (CLD)," and "Hepatology Communications," which provide peer-reviewed research on liver diseases. In terms of professional relations, AASLD develops clinical practice guidelines, practice metrics, collaborates with related societies, and engages with patients more actively. They also conduct a public and clinical policy program, organizing events like Liver Capitol Hill Day and Federal Agency Day to educate legislators and agency partners on liver disease issues. AASLD counts 58 employees in total and is committed to strengthening its patient engagement, increasing patient representation, and enhancing its advocacy initiatives. The organization also actively collaborates with other medical societies to further the science and practice of hepatology.
Official website here: www.aasld.org
Is American Association For The Study Of Liver Diseases legitimate?
American Association For The Study Of Liver Diseases is a legitimate nonprofit organization registered as a 501(c)(3) entity. American Association For The Study Of Liver Diseases submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $986,322
Professional Fundraising Fees: $19,800
Other Salaries and Wages: $3,293,893
For more financial information, click here
Official website here: www.aasld.org
What is the mission statement of American Association For The Study Of Liver Diseases?
The American Association for the Study of Liver Diseases (AASLD) is committed to advancing and disseminating the science and practice of hepatology. Their mission is to promote liver health and improve patient care. They achieve this through various initiatives, such as publishing peer-reviewed journals like "Hepatology" and "Liver Transplantation," which provide research on liver and biliary tract diseases. They also have an online learning resource called Clinical Liver Disease (CLD), addressing treatment issues faced by hepatologists. In terms of professional relations, AASLD develops clinical practice guidelines, has a Practice Metrics Committee, collaborates with related societies, and engages with patients to deepen their involvement. For clinical and public policies, AASLD conducts a public and clinical policy program, advocating for liver disease research and patient care in Congress and key federal agencies.
Official website here: www.aasld.org
Who is the CEO of American Association For The Study Of Liver Diseases?
Laurie Deleve is the Principal Officer of American Association For The Study Of Liver Diseases. The CEO's salary of American Association For The Study Of Liver Diseases is $488,774 and their total compensation is $565,276.
Official website here: www.aasld.org
What is the revenue of American Association For The Study Of Liver Diseases?
American Association For The Study Of Liver Diseases's revenue in 2022 was $8,439,460.
Official website here: www.aasld.org
Who are the executives of American Association For The Study Of Liver Diseases and what are their salaries?
The average compensation at American Association For The Study Of Liver Diseases during 2022 was $73,797. There are 58 employees and 355 volunteers at American Association For The Study Of Liver Diseases.
Here are 19 key members and their salaries (American Association For The Study Of Liver Diseases's CEO's salary is $488,774 and their total compensation is $565,276):
- Matthew D'Uva (Chief Executive Officer)
- Julie Deal (Aasld Deputy Exec. Dir./Fdn Ed)
- Mukarab Islam (Vp, Finance & Administration)
- Caroline Lauren (Vp, Marketing And Membership)
- Marjorie Bynum (Chief Of Staff)
- Audrey Davis-Owino (Sr. Dir., Clin. Guidelines/Quality)
- Crystal Jones (Dir., Human Resources)
- Ann Haran (Dir., Publications)
- Raymond T Chung (Past President) [Trustee/Director]
- Laurie D Deleve (President) [Trustee/Director]
- Vijay H Shah (Treasurer) [Trustee/Director]
- Norah Terrault (President-Elect) [Trustee/Director]
- Carla W Brady (Secretary) [Trustee/Director]
- W Ray Kim (Councilor) [Trustee/Director]
- Grace L Su (Councilor) [Trustee/Director]
- Saul J Karpen (Councilor) [Trustee/Director]
- Mary E Rinella (Councilor At Large) [Trustee/Director]
- Paul Martin (Councilor At Large) [Trustee/Director]
- Kim M Olthoff (Councilor At Large) [Trustee/Director]
Official website here: www.aasld.org
Where can I find the form 990 for American Association For The Study Of Liver Diseases?
The American Association For The Study Of Liver Diseases’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.aasld.org
Learn more at the official website: www.aasld.org
Mission Statement of American Association For The Study Of Liver Diseases
The American Association for the Study of Liver Diseases, often abbreviated as AASLD, is dedicated to advancing and disseminating the science and practice of hepatology, with the ultimate goal of promoting liver health and enhancing patient care. This nonprofit organization strives to achieve its mission by engaging in various activities, including the publication of peer-reviewed research journals such as "Hepatology" and "Liver Transplantation." These publications provide valuable information on the liver and biliary tract, their diseases, and liver transplantation.
Apart from its publishing initiatives, AASLD also focuses on professional relations. It develops clinical practice guidelines, which provide recommendations supported by a high level of scientific evidence to aid both practitioners and patients in making informed decisions regarding appropriate healthcare under specific clinical circumstances. Additionally, AASLD has a Practice Metrics Committee that aims to evaluate the quality of care provided to patients with liver diseases and stimulate quality improvement programs within the organization.
Moreover, AASLD collaborates with other medical societies both domestically and internationally to further the science and practice of hepatology. It also engages in patient engagement activities, such as increasing patient representation in its activities, increasing patient access to its expertise, and strengthening its advocacy initiatives. In terms of clinical and public policies, AASLD conducts a program supervised by the Public Policy Committee, which includes events like Liver Capitol Hill Day and Federal Agency Day. These events aim to educate legislators and federal agency partners on liver disease research and patient care, keeping its members informed of legislative and agency decisions related to hepatology.
Impact
This information is meant to be a general summary of American Association For The Study Of Liver Diseases. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The American Association for the Study of Liver Diseases (AASLD) has a significant impact on the field of hepatology and liver health. Through its publications, such as "Hepatology" and "Liver Transplantation," AASLD provides valuable peer-reviewed research on the liver and biliary tract, as well as state-of-the-art information on liver transplantation. Additionally, its online learning resource/journal, Clinical Liver Disease (CLD), addresses treatment issues faced by healthcare professionals dealing with liver diseases.
AASLD's professional relations activities, including the development of clinical practice guidelines supported by scientific evidence, aim to assist practitioners and patients in making informed healthcare decisions. The organization's Practice Metrics Committee and collaborations with related societies work towards improving quality of care for patients with liver diseases and stimulating quality improvement programs within the field of hepatology.
Furthermore, AASLD's engagement with patients through increased representation in its activities, improved access to expertise, and partnerships in advocacy initiatives demonstrates its commitment to enhancing patient care and involvement in liver health.
In the realm of clinical and public policies, AASLD conducts a public and clinical policy program supervised by the Public Policy Committee. Events like Liver Capitol Hill Day and Federal Agency Day allow for advocacy efforts to educate legislators and federal agency partners on liver disease research and patient care priorities. By keeping its members informed of legislative and agency decisions that impact hepatology, AASLD encourages active participation in public policy issues to advance liver health and quality patient care.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MEETINGS/EDUCATION
Revenue
$3,635,555
MEMBERSHIP DUES
Revenue
$1,620,859
PUBLICATIONS
Revenue
$877,303
PROFESSIONAL RELATIONS
Revenue
$80,616
CAREER DEVELOPMENT ADS
Revenue
$26,032
Organization Details
Founding Year
1950
Phone
(703) 299-9766
Principal Officer
Laurie Deleve
Main Address
1001 NORTH FAIRFAX STREET 400, ALEXANDRIA, VA, 223141587
Website
www.aasld.org
NTEE Category
Code: G400 - Disease
If you are a representative of American Association For The Study Of Liver Diseases and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.